A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).

被引：0
|
作者：
Li, Zhao
Xu, Peng-Fei
Mao, Wei-Min
Kuang, YuKang
Fan, Hai-Yin
Zou, Bin
Zhu, Jian-Feng
Li, Chao
Cheng, Xiao-Liang
Liu, Xing-Fei
Guo, Changying
机构：
[1] Jiangxi Prov Tumor Hosp, Nanchang, Peoples R China
[2] Nanchang Univ, Jiangxi Prov Tumor Hosp, Med Coll, Nanchang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16038
引用
收藏
页码：E16038 / E16038
页数：1
相关论文
共 50 条
  • [1] The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
    Lv, Huilai
    Huang, Chao
    Li, Jiachen
    Zhang, Fan
    Gai, Chunyue
    Liu, Zhao
    Xu, Shi
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [2] Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Lv, Huilai
    Tian, Yang
    Li, Jiachen
    Huang, Chao
    Sun, Bokang
    Gai, Chunyue
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Neoadjuvant durvalumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC)
    He, J.
    Zhao, L.
    Li, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1553 - S1553
  • [4] The efficacy and safety of neoadjuvant sintilimab combined with chemotherapy in elderly patients with locally advanced esophageal squamous cell carcinoma.
    Lv, Huilai
    Huang, Chao
    Li, Jiachen
    Zhang, Fan
    Gai, Chunyue
    Liu, Zhao
    Xu, Shi
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 378 - 378
  • [5] Neoadjuvant sintilimab combined with chemotherapy in patients with resectable esophageal squamous cell carcinoma (ESCC): Preliminary results from a phase II study.
    Guo, Jincheng
    Qiao, Chengrui
    Lu, Jiabin
    Yang, Shiqing
    Zhang, Boyi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16008 - E16008
  • [6] Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC).
    Lv, Huilai
    Tian, Yang
    Huang, Chao
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Zhao, Jidong
    He, Ming
    Li, Jie
    Li, Dan
    Zhao, Yang
    Li, Xinhui
    Zhang, Xiangmei
    Chen, Xin
    Liu, Yunjiang
    Zhao, Liyan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (04) : 324 - 331
  • [8] Neoadjuvant pembrolizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim results.
    Wang, Weiwei
    Li, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16011 - E16011
  • [9] Three courses of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective phase II clinical trial
    Yang, G.
    Sun, X.
    Yang, H.
    Luo, G.
    Zheng, Y.
    Huang, M.
    Wang, Z.
    Cai, P.
    He, H.
    Xiang, J.
    Cai, M.
    Fu, J.
    Liu, Q.
    Yi, H.
    Zhong, J.
    Huang, Y.
    Guo, Q.
    Zhang, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1122 - S1122
  • [10] Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
    Yu, Yong-kui
    Meng, Fan-Yu
    Wei, Xiu-feng
    Chen, Xian-kai
    Li, Hao-miao
    Liu, Qi
    Li, Can-jun
    Xie, Hou-nai
    Xu, Lei
    Zhang, Rui-xiang
    Xing, Wenqun
    Li, Yin
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (02):
12345